Diabetes and restenosis
Abstract Restenosis, defined as the re-narrowing of an arterial lumen after revascularization, represents an increasingly important issue in clinical practice. Indeed, as the number of stent placements has risen to an estimate that exceeds 3 million annually worldwide, revascularization procedures h...
Main Authors: | Scott Wilson, Pasquale Mone, Urna Kansakar, Stanislovas S. Jankauskas, Kwame Donkor, Ayobami Adebayo, Fahimeh Varzideh, Michael Eacobacci, Jessica Gambardella, Angela Lombardi, Gaetano Santulli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-022-01460-5 |
Similar Items
-
<span style="font-variant: small-caps">l</span>-Arginine and COVID-19: An Update
by: Ayobami Adebayo, et al.
Published: (2021-11-01) -
miR-4432 Targets FGFBP1 in Human Endothelial Cells
by: Roberta Avvisato, et al.
Published: (2023-03-01) -
Sortilin drives hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress
by: Fahimeh Varzideh, et al.
Published: (2022-02-01) -
miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
by: Urna Kansakar, et al.
Published: (2022-09-01) -
Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis
by: Fahimeh Varzideh, et al.
Published: (2022-04-01)